BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 240271)

  • 1. Characterization of Hex S, the major residual beta hexosaminidase activity in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease).
    Ikonne JU; Rattazzi MC; Desnick RJ
    Am J Hum Genet; 1975 Sep; 27(5):639-50. PubMed ID: 240271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexosaminidase isozyme in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease).
    Beutler E; Kuhl W; Comings D
    Am J Hum Genet; 1975 Sep; 27(5):628-38. PubMed ID: 808963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on complementation of beta hexosaminidase deficiency in human GM2 gangliosidosis.
    Rattazzi MC; Brown JA; Davidson RG; Shows TB
    Am J Hum Genet; 1976 Mar; 28(2):143-54. PubMed ID: 817596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile Sandhoff disease: some properties of the residual hexosaminidase in cultured fibroblasts.
    Wood S; MacDougall BG
    Am J Hum Genet; 1976 Sep; 28(5):489-95. PubMed ID: 10724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic study of GM2 gangliosidosis (Tay-Sachs and Sandhoff) by the study of the hexosaminidases of the Sandhoff-rodents hybrids (mouse and hamster)].
    Weil D; Van Cong N; Rebourcet R; Frézal J
    Ann Genet; 1975 Sep; 18(3):163-8. PubMed ID: 810067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical and biochemical investigation of hexosaminidase S.
    Geiger B; Arnon R; Sandhoff K
    Am J Hum Genet; 1977 Sep; 29(5):508-22. PubMed ID: 409285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
    Bayleran J; Hechtman P; Saray W
    Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic homology of feline and human beta-hexosaminidase.
    O'Neil DC; Bartholomew WR; Rattazzi MC
    Biochim Biophys Acta; 1979 Sep; 580(1):1-9. PubMed ID: 94833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of hexosaminadases in interspecific hybrids and in GM2 gangliosidosis with a discussion on their genetic control.
    Van Cong N; Weil D; Rebourcet R; Frézal J; Richard-Mollard AM
    Ann Hum Genet; 1975 Jul; 39(1):111-23. PubMed ID: 810068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tissue distribution of hexosaminidase S and hexosaminidase C.
    Beutler E; Kuhl W
    Ann Hum Genet; 1977 Oct; 41(2):163-7. PubMed ID: 413470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory diagnosis of canine GM2-gangliosidosis using blood and cerebrospinal fluid.
    Yamato O; Satoh H; Matsuki N; Ono K; Yamasaki M; Maede Y
    J Vet Diagn Invest; 2004 Jan; 16(1):39-44. PubMed ID: 14974845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine GM2-Gangliosidosis Sandhoff Disease Associated with a 3-Base Pair Deletion in the HEXB Gene.
    Wang P; Henthorn PS; Galban E; Lin G; Takedai T; Casal M
    J Vet Intern Med; 2018 Jan; 32(1):340-347. PubMed ID: 29106755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexosaminidase C in brain affected by Tay-Sachs Disease.
    Minami R; Nakamura F; Oyanagi K; Nakao T
    Tohoku J Exp Med; 1981 Feb; 133(2):175-85. PubMed ID: 7268761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein.
    Inui K; Grebner EE; Jackson LG; Wenger DA
    Am J Hum Genet; 1983 Jul; 35(4):551-64. PubMed ID: 6224417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of lymphoid cell line for enzymatic studies of GM2-gangliosidosis variant 0 (Sandhoff disease).
    Maret A; Salvayre R; Radon J; Hardy M; Vuillaume M; Lenoir G; Douste-Blazy L
    Enzyme; 1985; 34(1):48-56. PubMed ID: 3002784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of infantile and juvenile forms of GM2 gangliosidosis variant 0. Residual activities toward natural and different synthetic substrates.
    Kytzia HJ; Hinrichs U; Sandhoff K
    Hum Genet; 1984; 67(4):414-8. PubMed ID: 6436167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus transformed lymphoid cell lines as a new model system in culture for the study of GM2-gangliosidoses: Tay-Sachs and Sandhoff diseases.
    Maret A; Salvayre R; Negre A; Bes JC; Douste-Blazy L
    Biol Cell; 1985; 53(3):293-6. PubMed ID: 2990625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermodynamic determination of plasma and leukocyte beta-hexosaminidase isoenzymes in homozygote and heterozygote carriers for the GM2 gangliosidosis B1 variant.
    Casal JA; Pérez LF; Tutor JC
    Am J Clin Pathol; 2003 May; 119(5):684-8. PubMed ID: 12760286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and tissue distribution of N-acetyl hexosaminidase C: suggestive evidence for a separate hexosaminidase locus.
    Swallow DM; Evans L; Saha N; Harris H
    Ann Hum Genet; 1976 Jul; 40(1):55-66. PubMed ID: 9025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
    Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
    Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.